Inhibitors of sialyltransferases: potential roles in tumor growth and metastasis.
For over thirty years it has been evident that there is altered glycosyltransferase activity in neoplastic tissue when compared to healthy tissue. It has also long been speculated that disruption of the neoplastic expression of sialic acid on cellular glycoconjugates, is a valid target in anti-metastatic therapeutic development. Over the years attempts have been made to synthesize inhibitors of sialyltransferases in a effort to assist in the validation or dissolution of these enzymes as potential therapeutic targets.
Drinnan
N B
NB
Alchemia Pty Ltd, 3 Hi-Tech Court, Brisbane Technology Park, Eight Mile Plains, Qld 4113, Australia. NDrinnan@alchemia.com.au
Halliday
J
J
Ramsdale
T
T
D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D015394:Molecular Structure; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D012794:Sialic Acids / Q000378:metabolism; D012799:Sialyltransferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013329:Structure-Activity Relationship
D004791:Enzyme Inhibitors; D012794:Sialic Acids; D012799:Sialyltransferases